News for IDEXX Laboratories, Inc. (I1DX34.SA)

Shares of IDEXX Laboratories Inc (IDXX) fell 3.10% in mid-day trading on Feb 28. The stock reached an intraday low of $423.82, before recovering slightly to $

Robust product innovation and market leadership in veterinary diagnostics.Expansive global presence with a focus on enhancing veterinary practice efficiency.Ch

Baron WealthBuilder Fund, a compilation of Baron Funds, increased in the fourth quarter of 2024, outperforming its benchmark, the S&P 500 Index.

Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion amidst recent challenges. Read the full stock report here.

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

We recently published a list of Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries. In this article, we are going to take a look at where IDEXX Laboratories, Inc.

On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump had promised during his...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. ”œIDEXX had a s

While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated its earnings and revenue guidance for the full-year 2025, in line with analysts' estimates.

Revenue: $954 million for Q4 2024, surpassing the estimated $934.99 million, marking a 6% increase year-over-year.Earnings Per Share (EPS): Achieved $2.62 for

We recently compiled a list of the Jim Cramer Looked At These 7 Stocks Recently. In this article, we are going to take a look at where IDEXX Laboratories, Inc.

We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Business Model Mastery. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.

Baron Asset Fund declined in the fourth quarter of 2024, underperforming its benchmark, the Russell Midcap Growth Index. Click here to read the full commentary.

Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).

U.S. equity indices generated modest returns in the fourth quarter of 2024, and closed out the full year with double digit returns for the second year in a row.

Baron Focused Growth Fund advanced during the fourth quarter of 2024, outperforming its benchmark, the Russell 2500 Growth Index. Read more here.

Stocks To Buy: Cramer On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Robinhood HOOD. On Jan. 13, the U.S. Securities and Exchange Co...